Arvinas, Inc. Files Q1 2025 10-Q Financial Report
Ticker: ARVN · Form: 10-Q · Filed: May 1, 2025 · CIK: 1655759
| Field | Detail |
|---|---|
| Company | Arvinas, Inc. (ARVN) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
Related Tickers: ARVN
TL;DR
ARVN Q1 2025 10-Q filed. Financials out.
AI Summary
Arvinas, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported its financial results for the first quarter of 2025, detailing its assets, liabilities, and equity. Specific financial figures for the quarter and comparative periods are included in the filing.
Why It Matters
This filing provides investors with a detailed look at Arvinas' financial health and performance in the first quarter of 2025, crucial for understanding the company's operational status and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Arvinas faces inherent risks related to drug development, regulatory approvals, and market competition, which are reflected in its financial reporting.
Key Numbers
- 2025 Q1 — Reporting Period (First quarter of fiscal year 2025)
- 2024-12-31 — Prior Year End (Comparative balance sheet date)
- 2024-03-31 — Prior Year Q1 (Comparative income statement period)
Key Players & Entities
- ARVINAS, INC. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250501 (date) — Filing date
- 0001655759 (company) — Central Index Key for Arvinas, Inc.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 1, 2025.
What is the Central Index Key (CIK) for Arvinas, Inc.?
The Central Index Key for Arvinas, Inc. is 0001655759.
What is the fiscal year end for Arvinas, Inc.?
The fiscal year end for Arvinas, Inc. is December 31.
What SIC code is associated with Arvinas, Inc.?
Arvinas, Inc. is associated with SIC code 2834, Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding ARVINAS, INC. (ARVN).